Preston Klassen
Overview
Preston Klassen received an average of $6M in total compensation, including $412K in salary, at Metacrine between 2020 and 2021. Preston Klassen also received an average of $1M at Orexigen Therapeutics from 2009 to 2015.
- 2021
- 2020
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
MetacrinePresident and Chief Executive Officer
MetacrinePresident and Chief Executive Officer
Orexigen TherapeuticsExecutive Vice President, Global Product Development
Orexigen TherapeuticsExecutive Vice President, Global Product Development
Orexigen TherapeuticsExecutive Vice President, Global Product Development
Orexigen TherapeuticsHead of Global Contrave Program and Executive Vice President, Product Development
Orexigen TherapeuticsHead of Global NB32 Program and Senior Vice President, Product Development
Orexigen TherapeuticsHead of Global Contrave Program and Senior Vice President, Product Development
Orexigen TherapeuticsHead of Global Contrave Program and Senior Vice President, Product Development
Source: SEC filings on April 7, 2022, April 9, 2021, May 27, 2016, April 22, 2015, April 30, 2014, April 23, 2013, and April 27, 2012.
Related executives
We found 17 more executives who work or worked at Metacrine and Orexigen Therapeutics.
Patricia Millican
Metacrine
Chief Financial Officer
Hubert Chen
Metacrine
Chief Medical Officer
Catherine Lee
Metacrine
General Counsel
Ken Song
Metacrine
Chief Executive Officer
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
Thomas Lynch
Orexigen Therapeutics
General Counsel
Joseph Hagan
Orexigen Therapeutics